Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Hematopoietic stem cell‑based angiotensin‑(1‑7) delivery to the brain improves functional outcomefollowing cerebral ischemia.
Journal: Acta neurobiologiae experimentalis
Published: September 27, 2024
Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2/LMO2 γδ T-ALL as an extremely high risk leukemia in the very young.
Journal: medRxiv : the preprint server for health sciences
Published: November 21, 2023
EBV-driven lymphoid neoplasms associated with pediatric ALL maintenance therapy.
Journal: Blood
Published: June 29, 2022
Bevacizumab, With Sorafenib and Cyclophosphamide Provides Clinical Benefit for Recurrent or Refractory Osseous Sarcomas in Children and Young Adults.
Journal: Frontiers in oncology
Published: January 28, 2022
CPX-351 induces remission in newly diagnosed pediatric secondary myeloid malignancies.
Journal: Blood advances
Published: September 13, 2021
Clinical and biological aspects of myeloid leukemia in Down syndrome.
Journal: Leukemia
Published: June 18, 2021
Activity of venetoclax against relapsed acute undifferentiated leukemia.
Journal: Cancer
Published: January 11, 2021
Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery.
Journal: Neuro-oncology
Published: December 15, 2020
Allogeneic CAR Cell Therapy-More Than a Pipe Dream.
Journal: Frontiers in immunology
Published: October 16, 2020
Last Updated: 09/26/2026